Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism
Top Cited Papers
- 1 August 2012
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 303 (3), E334-E351
- https://doi.org/10.1152/ajpendo.00084.2012
Abstract
To identify new genes that are important in fat metabolism, we utilized the Lexicon-Genentech knockout database of genes encoding transmembrane and secreted factors and whole murine genome transcriptional profiling data that we generated for 3T3-L1 in vitro adipogenesis. Cross-referencing null models evidencing metabolic phenotypes with genes induced in adipogenesis led to identification of a new gene, which we named RIFL (refeeding induced fat and liver). RIFL-null mice have serum triglyceride levels approximately one-third of wild type. RIFL transcript is induced >100-fold during 3T3-L1 adipogenesis and is also increased markedly during adipogenesis of murine and human primary preadipocytes. siRNA-mediated knockdown of RIFL during 3T3-L1 adipogenesis results in an ∼35% decrease in adipocyte triglyceride content. Murine RIFL transcript is highly enriched in white and brown adipose tissue and liver. Fractionation of WAT reveals that RIFL transcript is exclusive to adipocytes with a lack of expression in stromal-vascular cells. Nutritional and hormonal studies are consistent with a prolipogenic function for RIFL. There is evidence of an approximately eightfold increase in RIFL transcript level in WAT in ob/ob mice compared with wild-type mice. RIFL transcript level in WAT and liver is increased ∼80- and 12-fold, respectively, following refeeding of fasted mice. Treatment of 3T3-L1 adipocytes with insulin increases RIFL transcript ≤35-fold, whereas agents that stimulate lipolysis downregulate RIFL. Interestingly, the 198-amino acid RIFL protein is predicted to be secreted and shows ∼30% overall conservation with the NH2-terminal half of angiopoietin-like 3, a liver-secreted protein that impacts lipid metabolism. In summary, our data suggest that RIFL is an important new regulator of lipid metabolism.Keywords
This publication has 82 references indexed in Scilit:
- Protein Phosphatase 5 Mediates Lipid Metabolism through Reciprocal Control of Glucocorticoid Receptor and Peroxisome Proliferator-activated Receptor-γ (PPARγ)Published by Elsevier BV ,2011
- Human resistin: found in translation from mouse to manTrends in Endocrinology & Metabolism, 2011
- Lipolysis – A highly regulated multi-enzyme complex mediates the catabolism of cellular fat storesProgress in Lipid Research, 2010
- Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicityTrends in Endocrinology & Metabolism, 2010
- Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)Published by Elsevier BV ,2009
- Re-expression of GATA2 Cooperates with Peroxisome Proliferator-activated Receptor-γ Depletion to Revert the Adipocyte PhenotypePublished by Elsevier BV ,2009
- The Angiopoietin-like Proteins ANGPTL3 and ANGPTL4 Inhibit Lipoprotein Lipase Activity through Distinct MechanismsJournal of Biological Chemistry, 2009
- Fat and Beyond: The Diverse Biology of PPARγAnnual Review of Biochemistry, 2008
- Wnt/β-catenin signaling in adipogenesis and metabolismCurrent Opinion in Cell Biology, 2007
- Differentiation-dependent expression of Adhfe1 in adipogenesisArchives of Biochemistry and Biophysics, 2007